Funders:

S:CORT is a consortium jointly funded by Cancer Research UK (CRUK) and the Medical Research Council (MRC) to help personalise colorectal (bowel) cancer treatment by matching patients to the most effective therapies.

Partners:

Our consortium is a collaboration between Academic, Industry, Charity and Patient Group Partners:

Academic Partners:

University of Oxford

Queen’s University Belfast

University of Birmingham

University of Leeds

Wellcome Trust Sanger Institute

MRC Clinical Trials Unit - UCL

Kings College London;

University of Aberdeen

 

Industry Partners:

Almac Diagnostics

About Almac Diagnostics:

Almac Diagnostics is a personalised medicine company focused on the discovery, development and commercialisation of diagnostic and companion diagnostic tests. These tests are aimed to guide patient treatment decisions which will ultimately improve care in a wide range of disease areas including colon cancer.

 

Strategic Partnerships:

Bowel Cancer UK

Northern Ireland Cancer Research Consumer Forum

European Organisation for Research and Treatment of Cancer

European Alliance for Personalised Medicine

European CanCer Organisation